Anthony Chang to Nephritis, Interstitial
This is a "connection" page, showing publications Anthony Chang has written about Nephritis, Interstitial.
Connection Strength
1.342
-
The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis. Semin Nephrol. 2015 Sep; 35(5):455-64.
Score: 0.504
-
Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgery. Clin J Am Soc Nephrol. 2006 Sep; 1(5):920-4.
Score: 0.268
-
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis Rheumatol. 2016 11; 68(11):2740-2751.
Score: 0.137
-
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol. 2014 Dec; 66(12):3359-70.
Score: 0.120
-
Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis. PLoS One. 2014; 9(3):e92051.
Score: 0.114
-
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):865-74.
Score: 0.094
-
The renal failure that vanished. J Hosp Med. 2010 Jul-Aug; 5(6):371-2.
Score: 0.088
-
Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol. 2007 Mar; 18(3):811-22.
Score: 0.017